The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

PWJC (Patrick) Serruys; Pim Feijter; R Benghozi; PG (Paul) Hugenholtz; E Lesaffre

doi:10.1080/14628840127765

The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

PWJC (Patrick) Serruys
, Pim Feijter
, R Benghozi
, PG (Paul) Hugenholtz
, E Lesaffre

Cardiology

Research output: Contribution to journal › Article › Academic

32 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	165-172
Number of pages	8
Journal	International Journal of Cardiovascular Interventions
Volume	4
DOIs	https://doi.org/10.1080/14628840127765
Publication status	Published - 2002

Access to Document

10.1080/14628840127765

http://hdl.handle.net/1765/72258

Cite this

Serruys, PWJC., Feijter, P., Benghozi, R., Hugenholtz, PG., & Lesaffre, E. (2002). The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease. International Journal of Cardiovascular Interventions, 4, 165-172. https://doi.org/10.1080/14628840127765

Serruys, PWJC (Patrick) ; Feijter, Pim ; Benghozi, R et al. / The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease. In: International Journal of Cardiovascular Interventions. 2002 ; Vol. 4. pp. 165-172.

@article{45b87aff8b454404adfa411fdaca97c4,

title = "The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease",

author = "Serruys, \{PWJC (Patrick)\} and Pim Feijter and R Benghozi and Hugenholtz, \{PG (Paul)\} and E Lesaffre",

year = "2002",

doi = "10.1080/14628840127765",

language = "Undefined/Unknown",

volume = "4",

pages = "165--172",

journal = "International Journal of Cardiovascular Interventions",

issn = "1471-1796",

publisher = "Taylor \& Francis Ltd (UK)",

}

Serruys, PWJC, Feijter, P, Benghozi, R, Hugenholtz, PG & Lesaffre, E 2002, 'The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease', International Journal of Cardiovascular Interventions, vol. 4, pp. 165-172. https://doi.org/10.1080/14628840127765

The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease. / Serruys, PWJC (Patrick); Feijter, Pim; Benghozi, R et al.
In: International Journal of Cardiovascular Interventions, Vol. 4, 2002, p. 165-172.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

AU - Serruys, PWJC (Patrick)

AU - Feijter, Pim

AU - Benghozi, R

AU - Hugenholtz, PG (Paul)

AU - Lesaffre, E

PY - 2002

Y1 - 2002

U2 - 10.1080/14628840127765

DO - 10.1080/14628840127765

M3 - Article

C2 - 12036459

SN - 1471-1796

VL - 4

SP - 165

EP - 172

JO - International Journal of Cardiovascular Interventions

JF - International Journal of Cardiovascular Interventions

ER -

Serruys PWJC, Feijter P, Benghozi R, Hugenholtz PG, Lesaffre E. The Lescol intervention prevention study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease. International Journal of Cardiovascular Interventions. 2002;4:165-172. doi: 10.1080/14628840127765